Exploring the association between statins use or HMG-CoA reductase inhibition and migraine: a systematic review and meta-analysis
Abstract Background Statins or 3‑hydroxy‑3‑methyl‑glutarylcoenzyme A (HMG‑CoA) reductase inhibitors are medications that act by reducing the cholesterol content of liver cells Moreover, statins have been found to improve endothelial function and reduce vascular wall inflammation. A growing body of r...
Saved in:
| Main Authors: | Hamdy A. Makhlouf, Amr K. Hassan, Nereen A. Almosilhy, Ahmed S.A. Osman, Shrouk Ramadan, Moaz Elsayed Abouelmagd |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-02-01
|
| Series: | The Journal of Headache and Pain |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s10194-025-01957-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EFFICACY OF HMG-CoA REDUCTASE INHIBITORS IN COVID-19 PATIENTS MORTALITY RATE: A META-ANALYSES OF RANDOMIZED CONTROL TRIALS
by: Mohammadreza Shafiei, et al.
Published: (2024-12-01) -
In silico approach for identification of potential tetracyclic triterpenoids from mushroom as HMG-CoA reductase inhibitor
by: Rishav Mazumder, et al.
Published: (2024-12-01) -
A novel approach to assessing the bioavailability of biopeptide inhibitor of HMG CoA reductase from germinated and ungerminated Kara Kratok (Phaseolus lunatus L.)
by: Cahyo Budiyanto, et al.
Published: (2025-04-01) -
A systematic review and meta-analysis of the effect of statins on osteoporotic fractures
by: Shahin Asgari-Savadjani, et al.
Published: (2024-06-01) -
Lipid liquid-crystalline nanoparticles as a suitable platform for accommodating sensitive membrane proteins: monitoring the activity of HMG-CoA reductase
by: Michalina Zaborowska-Mazurkiewicz, et al.
Published: (2025-05-01)